Neptune Technologies & Bioressources Inc. (Neptune) is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and NeuroBioPharmInc. The Neptune segment produces and commercializes nutraceutical products. The Company�s Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. The Company�s NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. The Company�s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO) which come in capsule form and serve as a dietary supplement to consumers.